Abstract: A pedicure sock for use following a pedicure, during and/or after toe nails are painted, to keep the feet warm without disturbing the toenail area includes a full front opening, full front closure, a split central sock body that forms an elongated, hollow member when closed, an open toe area integral with the distal end of the central sock body, and a heel section integral with the proximal end of the central sock body. The open toe section is defined by a plurality of attached toe separators, each of which is to be positioned between the toes and fastened in place on the top on a wearer's foot so as to allow the toes to be separated and extend outside of the sock when the rest of the foot is inside the sock. The full front opening/closure and toe separators allow for easy removal of the sock so as not to disturb the pedicure when the sock is removed.

Abstract: A pedicure sock for use following a pedicure, during and/or after toe nails are painted, to keep the feet warm without disturbing the toenail area includes a full front opening, full front closure, a split central sock body that forms an elongated, hollow member when closed, an open toe area integral with the distal end of the central sock body, and a heel section integral with the proximal end of the central sock body. The open toe section is defined by a plurality of attached toe separators, each of which is to be positioned between the toes and fastened in place on the top on a wearer's foot so as to allow the toes to be separated and extend outside of the sock when the rest of the foot is inside the sock. The full front opening/closure and toe separators allow for easy removal of the sock so as not to disturb the pedicure when the sock is removed.

Abstract: The present invention is directed to HPV polyepitope construct and the use thereof for the prevention and/or treatment of HPV infection.

Abstract: The present invention is directed to HPV polyepitope construct and the use thereoffor the prevention and/or treatment of HPV infection.

Abstract: The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.

Abstract: The present invention is directed to methods for selecting a variant of a peptide epitope which induces a CTL response against another variant(s) of the peptide epitope, by determining whether the variant comprises only conserved residues, as defined herein, at non-anchor positions in comparison to the other variant(s). The present invention is also directed to variants identified by the methods above; peptides comprising such variants; nucleic acids encoding such variants and peptides; cells comprising such variants, and/or peptides, and/or nucleic acids; compositions comprising such variants, and/or peptides, and/or nucleic acids, and/or cells; as well as therapeutic and diagnostic methods for using such variants, peptides, nucleic acids, cells, and compositions.

Abstract: This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare human papillomavirus (HPV) epitopes, and to develop epitope-based vaccines directed towards HPV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HPV infection.

Abstract: The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.

Abstract: This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare human immunodeficiency virus (HIV) epitopes, and to develop epitope-based vaccines directed towards HIV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HIV infection.